Santarus' ulcerative colitis drug gets FDA nod

01/14/2013 | Pharmaceutical Business Review Online

The FDA has granted Santarus approval for extended-release tablets of Uceris, or budesonide, for adults with ulcerative colitis. The firm is expected to bring the drug to market in March.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN